Drug intelligence / Profile preview

Bionanomatrix-OA

Development stage
Unknown
Lead developer
Endomimetics
Modality
Nanoparticles → Drug Delivery Systems, Peptides, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Implant, Topical
01

Overview

Bionanomatrix-OA is a peptide-based nanomatrix gel developed by Endomimetics for orthopedic applications, specifically for use in procedures such as knee implants. The technology is based on self-assembling peptide amphiphiles (PA) that form a nanomatrix with dual functionality: one component promotes endothelial cell binding to facilitate tissue integration and healing, while the other provides controlled, sustained release of nitric oxide (NO). In orthopedic settings, the gel can also be loaded with antibiotic-releasing liposomes (ABLipo) to prevent post-surgical infections and reduce the risk of arthrofibrosis. By creating a localized therapeutic environment at the implant site, Bionanomatrix-OA aims to enhance joint mobility and improve patient recovery outcomes.

Brand names
Bionanomatrix
Other names
Bionanomatrix OABionanomatrix (orthopedic applications)Bionanomatrix (NO-releasing gel for orthopedic use)
02

Targets

NO2- (Nitrite)

Beyond the preview

Go deeper on Bionanomatrix-OA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionanomatrix-OA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call